Cargando…
The Different Colors of mAbs in Solution
The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A therapeutic protein solution’s color may be d...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161444/ https://www.ncbi.nlm.nih.gov/pubmed/34073775 http://dx.doi.org/10.3390/antib10020021 |
_version_ | 1783700512826195968 |
---|---|
author | Ambrogelly, Alexandre |
author_facet | Ambrogelly, Alexandre |
author_sort | Ambrogelly, Alexandre |
collection | PubMed |
description | The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A therapeutic protein solution’s color may be determined by visual inspection or by more quantitative methods as per the different geographical area compendia. The nature and intensity of the color of a therapeutic protein solution is typically determined relative to calibrated standards. This review covers the analytical methodologies used for determining the color of a protein solution and presents an overview of protein variants and impurities known to contribute to colored recombinant therapeutic protein solutions. |
format | Online Article Text |
id | pubmed-8161444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81614442021-05-29 The Different Colors of mAbs in Solution Ambrogelly, Alexandre Antibodies (Basel) Review The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A therapeutic protein solution’s color may be determined by visual inspection or by more quantitative methods as per the different geographical area compendia. The nature and intensity of the color of a therapeutic protein solution is typically determined relative to calibrated standards. This review covers the analytical methodologies used for determining the color of a protein solution and presents an overview of protein variants and impurities known to contribute to colored recombinant therapeutic protein solutions. MDPI 2021-05-24 /pmc/articles/PMC8161444/ /pubmed/34073775 http://dx.doi.org/10.3390/antib10020021 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ambrogelly, Alexandre The Different Colors of mAbs in Solution |
title | The Different Colors of mAbs in Solution |
title_full | The Different Colors of mAbs in Solution |
title_fullStr | The Different Colors of mAbs in Solution |
title_full_unstemmed | The Different Colors of mAbs in Solution |
title_short | The Different Colors of mAbs in Solution |
title_sort | different colors of mabs in solution |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161444/ https://www.ncbi.nlm.nih.gov/pubmed/34073775 http://dx.doi.org/10.3390/antib10020021 |
work_keys_str_mv | AT ambrogellyalexandre thedifferentcolorsofmabsinsolution AT ambrogellyalexandre differentcolorsofmabsinsolution |